Mach7 Technologies Sets Date for Q3 FY26 Results and Investor Webinar

The latest announcement is out from Mach7 Technologies ( (AU:M7T) ).

Mach7 Technologies will release its Q3 FY26 results for the quarter ended 31 March 2026 on 24 April 2026 and will follow the announcement with a Zoom webinar for investors hosted by CEO Teri Thomas, CFO Dan Lee and EVP of Sales and Marketing Todd Stallard. The scheduled briefing, which allows investors to submit questions in advance or via live Q&A and will be posted as a recording on the company’s investor relations site, underlines Mach7’s ongoing investor engagement efforts and offers stakeholders a timely forum to assess the company’s operational and financial performance in the medical imaging software market.

The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.76 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.

More about Mach7 Technologies

Mach7 Technologies is an ASX-listed healthcare software company specialising in medical imaging solutions that enable health systems to securely store, access and share diagnostic images across disparate systems. Its flagship Enterprise Imaging Solution combines a Vendor Neutral Archive, the eUnity enterprise diagnostic viewer and workflow applications, serving customers from large integrated delivery networks and national health systems to independent provider groups and private radiology practices worldwide.

YTD Price Performance: -54.15%

Average Trading Volume: 217,345

Technical Sentiment Signal: Sell

Current Market Cap: A$66.39M

For detailed information about M7T stock, go to TipRanks’ Stock Analysis page.